首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1505217

全球血小板衍生生長因子 (PDGF) 市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Platelet-derived Growth Factors (PDGFs) Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年06月01日 | 出版商:

Value Market Research | 英文 171 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2032 年，全球血小板衍生生長因子 (PDGF) 市場的市場規模將從 2023 年的 2.574 億美元達到近 4.939 億美元，2024-2032 年研究期間複合年成長率為 7.51%。

血小板衍生生長因子 (PDGF) 是血小板中存在的蛋白質。它們對於傷口癒合和組織再生至關重要，並影響增殖、遷移和血管生成等基本細胞功能。當發生損傷時，血小板會釋放 PDGF 以吸引組織修復所需的細胞，例如纖維母細胞和平滑肌細胞。 PDGF 在治療上用於促進慢性傷口、手術部位和骨科損傷的癒合。透過促進身體的自然癒合過程，PDGF 有助於加速康復並改善再生療法的效果。

市場動態

血小板衍生生長因子（PDGF）市場因其在傷口癒合和組織再生的關鍵作用而受到推動。壓瘡和糖尿病足潰瘍等慢性傷口發生率的激增，顯著增加了 PDGF 的需求。生物技術的進步使得開發出更有效、更有針對性的 PDGF 製劑成為可能，從而增強了其治療潛力。再生醫學和組織工程技術的日益普及進一步推動了血小板衍生生長因子（PDGF）市場的發展。此外，醫療保健專業人員對 PDGF 在加速癒合過程中的益處的認知不斷提高，這推動了它們在臨床環境中的使用。老年人口的不斷增加，更容易受到慢性傷口和手術的影響，也促進了市場的成長。此外，旨在探索PDGF新應用的研發活動的大量投資預計將創造新的成長機會。然而，複雜的監管環境和高昂的生產成本可能會挑戰未來幾年血小板衍生生長因子（PDGF）市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球血小板衍生生長因子 (PDGF) 市場的各個細分市場進行了包容性評估。血小板衍生生長因子 (PDGF) 產業的成長和趨勢為本研究提供了整體方法。

市場區隔

血小板衍生生長因子（PDGF）市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按類型

PDGF-AA
PDGF-BB
PDGF-CC
PDGF-DD
PDGF-AB

按申請

骨科手術
心臟手術
癌症治療
傷口癒合
其他

按最終用戶

醫院
診所
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲地區血小板衍生生長因子 (PDGF) 市場的當前和未來需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。血小板衍生生長因子 (PDGF) 市場的主要參與者包括 Thermo Fisher Scientific Inc. (PeproTech Inc.)、Stryker、Sigma-Aldrich (Merck KGaA)、OriGene Technologies、IXCells Biotechnologies、Abbexa Ltd、Bio-Techne、Stemcell技術、神經組學、金斯瑞生物科技公司。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：血小板衍生生長因子 (PDGFS) 公司的競爭格局

血小板衍生生長因子（PDGF）市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Thermo Fisher Scientific Inc. (PeproTech Inc.)

公司簡介
公司收入
產品
最近的發展

Stryker

公司簡介
公司收入
產品
最近的發展

Sigma-Aldrich (Merck KGaA)

公司簡介
公司收入
產品
最近的發展

OriGene Technologies

公司簡介
公司收入
產品
最近的發展

IXCells Biotechnologies

公司簡介
公司收入
產品
最近的發展

Abbexa Ltd

公司簡介
公司收入
產品
最近的發展

Bio-Techne

公司簡介
公司收入
產品
最近的發展

Stemcell Technologies

公司簡介
公司收入
產品
最近的發展

Neuromics

公司簡介
公司收入
產品
最近的發展

GenScript Biotech Corporation

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112114931

The global demand for Platelet-derived Growth Factors (PDGFs) Market is presumed to reach the market size of nearly USD 493.9 Million by 2032 from USD 257.4 Million in 2023 with a CAGR of 7.51% under the study period 2024-2032.

Platelet-derived growth factors (PDGFs) are proteins present in platelets. They are pivotal for wound healing and tissue regeneration and influence essential cellular functions such as proliferation, migration, and angiogenesis. When an injury occurs, platelets release PDGFs to attract cells necessary for tissue repair, such as fibroblasts and smooth muscle cells. PDGFs are used therapeutically in treatments to enhance healing in chronic wounds, surgical sites, and orthopedic injuries. By promoting the body's natural healing processes, PDGFs help accelerate recovery and improve the outcomes of regenerative therapies.

MARKET DYNAMICS

The platelet-derived growth factors (PDGFs) market is driven by their critical role in wound healing and tissue regeneration. The surging incidence of chronic wounds, such as pressure sores and diabetic foot ulcers, has significantly boosted the demand for PDGFs. Advancements in biotechnology have enabled the development of more effective and targeted PDGF formulations, enhancing their therapeutic potential. The growing uptake of regenerative medicine and tissue engineering techniques further propels the platelet-derived growth factors (PDGFs) market. Additionally, the escalating awareness among healthcare professionals about the benefits of PDGFs in accelerating the healing process is driving their usage in clinical settings. The expanding elderly population, more susceptible to chronic wounds and surgeries, also contributes to market growth. Moreover, substantial investments in research and development activities aimed at exploring new applications of PDGFs are expected to create new growth opportunities. However, the complex regulatory environment and high production costs may challenge the platelet-derived growth factors (PDGFs)market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Platelet-derived Growth Factors (PDGFs). The growth and trends of Platelet-derived Growth Factors (PDGFs) industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Platelet-derived Growth Factors (PDGFs) market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

PDGF-AA
PDGF-BB
PDGF-CC
PDGF-DD
PDGF-AB

By Application

Orthopedic Surgeries
Cardiac Surgeries
Cancer Treatment
Wound Healing
Others

By End-User

Hospitals
Clinics
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Platelet-derived Growth Factors (PDGFs) market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Platelet-derived Growth Factors (PDGFs) market include Thermo Fisher Scientific Inc. (PeproTech Inc.), Stryker, Sigma-Aldrich (Merck KGaA), OriGene Technologies, IXCells Biotechnologies, Abbexa Ltd, Bio-Techne, Stemcell Technologies, Neuromics, GenScript Biotech Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PLATELET-DERIVED GROWTH FACTORS (PDGFS) - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-User
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PLATELET-DERIVED GROWTH FACTORS (PDGFS) MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. PDGF-AA Historic and Forecast Sales By Regions
5.4. PDGF-BB Historic and Forecast Sales By Regions
5.5. PDGF-CC Historic and Forecast Sales By Regions
5.6. PDGF-DD Historic and Forecast Sales By Regions
5.7. PDGF-AB Historic and Forecast Sales By Regions

6. GLOBAL PLATELET-DERIVED GROWTH FACTORS (PDGFS) MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Orthopedic Surgeries Historic and Forecast Sales By Regions
6.4. Cardiac Surgeries Historic and Forecast Sales By Regions
6.5. Cancer Treatment Historic and Forecast Sales By Regions
6.6. Wound Healing Historic and Forecast Sales By Regions
6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL PLATELET-DERIVED GROWTH FACTORS (PDGFS) MARKET ANALYSIS BY END-USER

7.1. Overview By End-User
7.2. Historical and Forecast Data Analysis By End-User
7.3. Hospitals Historic and Forecast Sales By Regions
7.4. Clinics Historic and Forecast Sales By Regions
7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL PLATELET-DERIVED GROWTH FACTORS (PDGFS) MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE PLATELET-DERIVED GROWTH FACTORS (PDGFS) COMPANIES

9.1. Platelet-derived Growth Factors (PDGFs) Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF PLATELET-DERIVED GROWTH FACTORS (PDGFS) INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Thermo Fisher Scientific Inc. (PeproTech Inc.)
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Stryker
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Sigma-Aldrich (Merck KGaA)
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. OriGene Technologies
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. IXCells Biotechnologies
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Abbexa Ltd
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Bio-Techne
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Stemcell Technologies
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Neuromics
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. GenScript Biotech Corporation
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Type (USD MN)
PDGF-AA Market Sales By Geography (USD MN)
PDGF-BB Market Sales By Geography (USD MN)
PDGF-CC Market Sales By Geography (USD MN)
PDGF-DD Market Sales By Geography (USD MN)
PDGF-AB Market Sales By Geography (USD MN)
Analysis By Application (USD MN)
Orthopedic Surgeries Market Sales By Geography (USD MN)
Cardiac Surgeries Market Sales By Geography (USD MN)
Cancer Treatment Market Sales By Geography (USD MN)
Wound Healing Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Analysis By End-User (USD MN)
Hospitals Market Sales By Geography (USD MN)
Clinics Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Platelet-derived Growth Factors (PDGFs) Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition